Olema Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$96,655,000 over the previous period. Total operating expenses were $104,961,000.
Profit Margin
| 2018 | 0 | -2.19M | |
|---|---|---|---|
| 2019 | 0 | -4.31M | |
| 2020 | 0 | -22.76M | |
| 2021 | 0 | -70.88M | |
| 2022 | 0 | -102.58M | |
| 2023 | 0 | -96.65M |
OLMA Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 377K | 1.65M | 1.66M | 11K | 9.03K | 0 |
Gross profit | -377K | -1.65M | -1.66M | -11K | -9.03K | 0 |
Operating exp. | ||||||
Research and development | 86.14M | 82.27M | 51.1M | 13.70M | 3.92M | 1.69M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 104.96M | 106.98M | 71.49M | 21.52M | 4.32M | 2.07M |
Operating income | -104.96M | -106.98M | -71.49M | -21.52M | -4.32M | -2.07M |
Other income (expenses), net | 8.30M | 2.20M | 395K | -593K | 7K | -94K |
Income before tax | -96.65M | -104.78M | -71.09M | -22.12M | -4.31M | -2.19M |
Income tax expense | 0 | -2.20M | -210K | 642K | 0 | -90K |
Net income | -96.65M | -102.58M | -70.88M | -22.76M | -4.31M | -2.19M |
Earnings per share | ||||||
Basic EPS | -2.14 | -2.56 | -1.79 | -0.58 | -0.11 | -0.16 |
Diluted EPS | -2.14 | -2.56 | -1.79 | -0.58 | -0.11 | -0.16 |
| Data source | Data source | Data source | Data source |